Cargando…
Treatment and chemoprevention of NSAID-associated gastrointestinal complications
The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, i...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697523/ https://www.ncbi.nlm.nih.gov/pubmed/19436617 |
_version_ | 1782168334166392832 |
---|---|
author | Frech, Edward J Go, Mae F |
author_facet | Frech, Edward J Go, Mae F |
author_sort | Frech, Edward J |
collection | PubMed |
description | The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients’ risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications. |
format | Text |
id | pubmed-2697523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26975232009-06-17 Treatment and chemoprevention of NSAID-associated gastrointestinal complications Frech, Edward J Go, Mae F Ther Clin Risk Manag Review The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients’ risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications. Dove Medical Press 2009 2009-03-26 /pmc/articles/PMC2697523/ /pubmed/19436617 Text en © 2009 Frech and Go, publisher and licensee Dove Medical Press Ltd. |
spellingShingle | Review Frech, Edward J Go, Mae F Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title | Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title_full | Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title_fullStr | Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title_full_unstemmed | Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title_short | Treatment and chemoprevention of NSAID-associated gastrointestinal complications |
title_sort | treatment and chemoprevention of nsaid-associated gastrointestinal complications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697523/ https://www.ncbi.nlm.nih.gov/pubmed/19436617 |
work_keys_str_mv | AT frechedwardj treatmentandchemopreventionofnsaidassociatedgastrointestinalcomplications AT gomaef treatmentandchemopreventionofnsaidassociatedgastrointestinalcomplications |